Km. Slunt et al., EFFECT OF MITONAFIDE ANALOGS ON TOPOISOMERASE-II OF LEISHMANIA-CHAGASI, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 706-709
Mitonafide (4-nitro-benzoisoquinolinedione) and a number of structural
analogs were synthesized and studied in order to determine the struct
ural requirements for inhibition of leishmanial nuclear and kinetoplas
t topoisomerase II and human topoisomerase II. The structure-activity
relationship studies with the mitonafide analogs demonstrated that the
re was selective targeting of leishmanial nuclear topoisomerase II and
human topoisomerase II and differential targeting of kinetoplast over
nuclear topoisomerase II in the parasite. Mitonafide analogs appeared
to have multiple mechanisms of action leading to death of leishmanias
, but several compounds that affected kinetoplast but not nuclear topo
isomerase II were not cytotoxic as determined by short-term assays. Th
ese studies provide new insight into the differential sensitivities of
leishmanial nuclear and kinetoplast topoisomerase II to topoisomerase
II-targeting drugs.